Compounds > ondansetron
Page last updated: 2024-11-01

ondansetron and Carcinoma, Oat Cell

ondansetron has been researched along with Carcinoma, Oat Cell in 1 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DiStasio, SA1

Other Studies

1 other study available for ondansetron and Carcinoma, Oat Cell

ArticleYear
Zofran makes chemo bearable.
    RN, 1993, Volume: 56, Issue:5

    Topics: Antineoplastic Agents; Carcinoma, Small Cell; Lung Neoplasms; Nausea; Ondansetron

1993